Localized Bullous Eruption Away From Injection Site,Caused by Intramuscular Meglumine Antimoniate Administration

Abstract

Get full access to this article

View all access options for this article.

References

Córdoba

Gandolfo Cano

Aguado

. Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis. Allergy. 2012;67:1609-1611.

Naranjo

Busto

Sellers

. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.

Esfandiarpour

Farajzadeh

Rahnama

Fathabadi

Heshmatkhah

Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis. Int J Dermatol. 2012;51:1221-1225.

Aste

Pau

Ferreli

Biggio

Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate. Br J Dermatol. 1998;138:370-371.

Jeddi

Caumes

Thellier

Jauréguiberry

Mazier

Buffet

PA.

Drug hypersensitivity syndrome induced by meglumine antimoniate. Am J Trop Med Hyg. 2009;80:939-940.